BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more
BIORETEC OY (0TN) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BIORETEC OY (0TN) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BIORETEC OY - Net Assets Trend (None–None)
This chart illustrates how BIORETEC OY's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BIORETEC OY (None–None)
The table below shows the annual net assets of BIORETEC OY from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BIORETEC OY's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BIORETEC OY Competitors by Market Cap
The table below lists competitors of BIORETEC OY ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
O Bank No. 1 REIT
TW:01009T
|
$1.69K |
|
ORIX Leasing Pakistan Limited
KAR:OLPL
|
$1.69K |
|
XCana Petroleum Corporation
PINK:XCPT
|
$1.69K |
|
Mahaweli Coconut Plantations Ltd
CM:MCPLN0000
|
$1.69K |
|
Crescent Fibres Limited
KAR:CFL
|
$1.68K |
|
Agritech Ltd
KAR:AGL
|
$1.68K |
|
Jujubee SA
WAR:JJB
|
$1.68K |
|
Comaliment Resita SA
RO:OMAL
|
$1.68K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIORETEC OY's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BIORETEC OY's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BIORETEC OY utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BIORETEC OY's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIORETEC OY (0TN) | €- | N/A | N/A | $1.68K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |